Argent BioPharma Ltd. (ASX: RGT) (OTCQB: RGTLF) has made significant progress in its collaboration with SINTEF to enhance antimicrobial therapies for chronic wounds and potential oncologic wound care.

MiscellaneousBIOVERSYS SUCCESSFULLY ADVANCES BV500 NTM PROGRAM WITH CONTINUED SUPPORT FROM CF AMR SYNDICATE 11.02.2025 / 07:00 CET/CESTBasel, Switzerland. February 11, 2025, 7am CET  BV500 reaches ...

Antibiotic resistance occurs when bacteria evolve mechanisms to withstand the drugs designed to eliminate them. This ...

CO2 laser skin resurfacing has become an immensely popular anti-aging treatment thanks to its ability to reduce wrinkles, ...

Antibiotic resistance is a mounting global health threat, posing serious challenges to both human and animal health. It ...

Most of Dr. Leah Schrupp’s patients know it. So do most of Dr. Erin Knudtson’s patients. If they visit their doctor with a runny nose, chest cold or the usual flu symptoms, they ...

Starpharma Holdings Limited (OTCMKTS:SPHRY – Get Free Report) shares fell 7.6% on Friday . The stock traded as low as $0.58 and last traded at $0.67. 500 shares were traded during trading, a decline ...

Daltonganj: A surprise inspection by the civil surgeon at Pindrahi Health Sub-Centre under Chhaterpur Sub-Divisional Hospital ...

Wolters Kluwer announced KLAS Research recognized Sentri7 clinical surveillance solution as Best in KLAS for infection ...

SRINAGAR: In a landmark achievement for India’s pharmaceutical sector, the country has introduced its first indigenous ...

Copyright: © 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.